Erratum For: Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells

Cellular Physiology and Biochemistry - Switzerland
doi 10.33594/000000135
Full Text
Abstract

Available in full text

Categories
Physiology
Date
Authors

Unknown

Publisher

Cell Physiol Biochem Press GmbH and Co KG

Related search

Selective Targeting of KRAS Oncogenic Alleles by CRISPR/Cas9 Inhibits Proliferation of Cancer Cells

Scientific Reports
Multidisciplinary
2018English

A Universal, Genomewide GuideFinder for CRISPR/Cas9 Targeting in Microbial Genomes

mSphere
MicrobiologyMolecular Biology
2020English

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era

Frontiers in Immunology
AllergyImmunology
2017English

Targeting N-Terminal Huntingtin With a Dual-sgRNA Strategy by CRISPR/Cas9

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

MiR-20a-5p Represses the Multi-Drug Resistance of Osteosarcoma by Targeting the SDC2 Gene

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

Pop In, Pop Out: A Novel Gene-Targeting Strategy for Use With CRISPR-Cas9

Genome Biology
2015English

Unsupervised Correction of Gene-Independent Cell Responses to CRISPR-Cas9 Targeting

BMC Genomics
BiotechnologyGenetics
2018English

Lack of Synergy for Inhibitors Targeting a Multi-Drug Resistant Hiv-1 Protease

2002English

Viral Diversity Is an Obligate Consideration in CRISPR/Cas9 Designs for Targeting the HIV Reservoir

BMC Biology
Developmental BiologyEvolutionEcologyGeneticsCell BiologyMolecular BiologyBiochemistryBiological SciencesSystematicsStructural BiologyPlant ScienceBehaviorBiotechnologyAgriculturalPhysiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy